The week's pick
Reseach Article
Enhanced Drug Anti-Counterfeiting and Verification System for the Pharmaceutical Drug Supply Chain using Blockchain
| International Journal of Computer Applications |
| Foundation of Computer Science (FCS), NY, USA |
| Volume 174 - Number 21 |
| Year of Publication: 2021 |
| Authors: Eseosa Ehioghae, Sunday Idowu, Oluwaseun Ebiesuwa |
10.5120/ijca2021921105
|
Eseosa Ehioghae, Sunday Idowu, Oluwaseun Ebiesuwa . Enhanced Drug Anti-Counterfeiting and Verification System for the Pharmaceutical Drug Supply Chain using Blockchain. International Journal of Computer Applications. 174, 21 ( Feb 2021), 1-12. DOI=10.5120/ijca2021921105
Abstract
The safety of the pharmaceutical drug supply chain is a major concern for global public health as the plague of drug counterfeiting along the supply chain is an increasing threat to the health of everyone. Various solutions have been proposed to solve the problem, yet, the problem is still rife, as estimates reveal that between 10% – 30% of drugs in the developed and developing countries respectively are counterfeit. This research proposes an enhanced drug anti-counterfeiting and verification system, using blockchain, to counter the plague of drug counterfeiting along the supply chain, while providing a suitable means of verifying such drugs. Two germane smart contracts – shipDrug and receiveDrug – were defined to serve as a means of safely moving drugs from one supply chain actor to the other, to secure the drug supply chain from the infiltration of counterfeit drugs. The system was implemented on the Hyperledger Fabric. The implemented system effectively secured the supply chain by allowing only the valid supply chain actors to execute the defined smart contracts. Final consumers were able to verify a drug by using a unique identifier associated with that drug to query the transaction history from the blockchain ledger. Hyperledger Caliper was used to evaluate the proposed system where it was revealed that an optimal throughput of 46 drug verifications per second was obtained, with less utilization of CPU and memory resources. The health ramifications of drug counterfeiting and the findings from this research make it imperative to consider the proposed system as an effective drug anti-counterfeiting system. Finally, it was recommended that the global health authority could implement the system on a global scale, after a smaller scale implementation, such as within countries, to determine its effectiveness in securing the drug supply chain within such jurisdictions.
References
- P. N. Newton, M. D. Green and F. M. Fernández, "Impact of poor-quality medicines in the ‘developing’ world," Trends in Pharmacological Sciences, vol. 31, no. 3, pp. 99-101, 2010.
- World Health Organization, "Frequently asked questions," 2005. [Online]. Available: https://www.who.int/medicines/services/counterfeit/faqs/QandAsUpdateJuly11.pdf. [Accessed 22 November 2020].
- World Health Organization, "Substandard and falsified medical products," 2018. [Online]. Available: https://www.who.int/en/news-room/fact-sheets/detail/substandard-and-falsified-medical-products. [Accessed 2 October 2020].
- A. Attaran, D. Barry, S. Basheer, R. Bate, D. Benton, J. Chauvin, L. Garrett, I. Kickbusch, J. C. Kohler, K. Midha, P. N. Newton, S. Nishtar, P. Orhii and M. McKee, "How to achieve international action on falsified and substandard medicines," BMJ, vol. 345, 2012.
- P. N. Newton, M. D. Green, F. M. Fernández, N. P. J. Day and N. J. White, "Counterfeit anti-infective drugs," The Lancet. Infectious Diseases, vol. 6, no. 9, pp. 602-613, 2006.
- R. Cockburn, P. N. Newton, E. K. Agyarko, D. Akunyili and N. J. White, "The Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers," PLOS Medicine, vol. 2, no. 4, pp. 0302-0308, 2005.
- World Health Organization, "1 in 10 medical products in developing countries is substandard or falsified," 28 November 2017. [Online]. Available: https://www.who.int/en/news-room/detail/28-11-2017-1-in-10-medical-products-in-developing-countries-is-substandard-or-falsified. [Accessed 30 August 2020].
- R. Liu and S. Lundin, "Falsified Medicines: Literature review," Working Papers in Medical Humanities, vol. 2, no. 1, pp. 1-25, 2016.
- N. Shah, "Pharmaceutical supply chains: key issues and strategies for optimization," Computers & Chemical Engineering, vol. 28, no. 6-7, pp. 929-941, 2004.
- M. Tremblay, "Medicines Counterfeiting is a Complex Problem: A Review of Key Challenges Across the Supply Chain," Current Drug Safety, vol. 8, no. 1, pp. 43-55, 2013.
- M. Paik, J. Chen and L. Subramanian, "Epothecary: Cost-effective Drug Pedigree Tracking and Authentication Using Mobile Phones," in 1st ACM SIGCOMM Workshop on Networking, Systems, and Applications for Mobile Handhelds, Barcelona, 2009.
- S. Choi and C. Poon, "An RFID-based Anti-counterfeiting System," IAENG International Journal of Computer Science, vol. 35, no. 1, 2008.
- S. u. Rehman, R. U. Rasool, M. S. Ayub, S. Ullah, A. Kamal, Q. M. Rajpoot and Z. Anwar, "Reliable Identification of Counterfeit Medicine Using Camera Equipped Mobile Phones," in 8th International Conference on High-capacity Optical Networks and Emerging Technologies, Riyadh, 2011.
- M. Wazid, A. K. Das, M. K. Khan, A. A.-D. Al-Ghaiheb, N. Kumar and A. V. Vasilakos, "Secure Authentication Scheme for Medicine Anti-counterfeiting System in IoT Environment," IEEE Internet of Things Journal, vol. 4, no. 5, pp. 1634-1646, 2017.
- S. Nakamoto, "Bitcoin: A Peer-to-Peer Electronic Cash System," 2008. [Online]. Available: https://bitcoin.org/bitcoin.pdf. [Accessed 29 September 2020].
- M. Mettler, "Blockchain Technology in Healthcare The Revolution Starts Here," in 2016 IEEE 18th International Conference on e-Health Networking, Applications and Services (Healthcom), Munich, 2016.
- M. Kassab, J. DeFranco, T. Malas, P. Laplante, G. Destefanis and V. V. G. Neto, "Exploring Research in Blockchain for Healthcare and a Roadmap for the Future," IEEE Transactions on Emerging Topics in Computing, 2019.
- M. Paik, A. Sharma, A. Meacham, G. Quarta, P. Smith, J. Trahanas, B. Levine, M. A. Hopkins, B. Rapchak and L. Subramanian, "The Case for SmartTrack," in 2009 International Conference on Information and Communication Technologies and Development (ICTD), Doha, 2009.
- Y. Huang, J. Wu and C. Long, "Drugledger: A Practical Blockchain System for Drug Traceability and Regulation," in 2018 IEEE International Conference on Internet of Things (iThings) and IEEE Green Computing and Communications (GreenCom) and IEEE Cyber, Physical and Social Computing (CPSCom) and IEEE Smart Data (SmartData), Halifax, 2018.
- K. Toyoda, T. P. Mathiopoulos, I. Sasase and T. Ohtsuki, "A Novel Blockchain-Based Product Ownership Management System (POMS) for Anti-Counterfeits in The Post Supply Chain," IEEE Access, vol. 5, pp. 17465-17477, 2017.
- P. Sylim, F. Liu, A. Marcelo and P. Fontelo, "Blockchain Technology for Detecting Falsified and Substandard Drugs in Distribution: Pharmaceutical Supply Chain Intervention," JMIR Research Protocols, vol. 7, no. 9, 2018.
- A. Litke, D. Anagnostopoulos and T. Varvarigou, "Blockchains for Supply Chain Management: Architectural Elements and Challenges Towards a Global Scale Deployment," Logistics, vol. 3, no. 1, 2019.
- GS1 US, "How to Translate a U.P.C. to a GTIN to an SGTIN to an EPC," 2019. [Online]. Available: https://www.gs1us.org/DesktopModules/Bring2mind/DMX/Download.aspx?Command=Core_Download&EntryId=389&language=en-US&PortalId=0&TabId=134. [Accessed 12 December 2020].
Index Terms
Keywords